BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

759828

215295

CURIS

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Curis Lifesciences Ltd performance

Today’s low

Today’s high

₹ 133.95 ₹ 137.00
₹ 133.95

52 week low

52 week high

₹ 133.95 ₹ 147.90
₹ 133.95

Open Price

₹ 133.95

Prev. Close

₹ 141.00

Volume (Shares)

17000.00

Total traded value

₹ 22.77

Upper Circuit

₹ 148.05

Lower Circuit

₹ 133.95

info

Curis Lifesciences Ltd Share Price Update

As of the latest trading session, Curis Lifesciences Ltd share price is currently at ₹ 133.95, which is down by ₹ -7.05 from its previous closing. Today, the stock has fluctuated between ₹ 133.95 and ₹ 137.00. Over the past year, Curis Lifesciences Ltd has achieved a return of [-] %. In the last month alone, the return has been [-] %. Read More...

Investment Returns

Over 1 Month 0.00% Over 3 Months 0.00% Over 6 Months 0.00% Over 1 Year 0.00%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Curis Lifesciences Ltd fundamentals


  • Market cap (Cr)

    114.00

  • P/E Ratio (TTM)

    18.68

  • Beta

    0.00

  • Book Value / share

    54.11

  • Return on equity

    55.32%

  • EPS (TTM)

    7.55

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    0.00

info icon alternate text
  • Market cap (Cr)

    0.0

  • P/E Ratio (TTM)

    0.0

  • Beta

    0.0

  • Book Value / share

    0.0

  • Return on equity

    0.0%

  • EPS (TTM)

    0.0

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    0.0

info icon alternate text

Curis Lifesciences Ltd Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 35.66
Operating Expense 28.74
Net Profit 5.57
Net Profit Margin (%) 15.61
Earnings Per Share (EPS) 111.39
EBITDA 8.76
Effective Tax Rate (%) 22.95
Particulars MAR 2023 (Values in Cr)
Revenue 35.50
Operating Expense 34.21
Net Profit 1.12
Net Profit Margin (%) 3.15
Earnings Per Share (EPS) 22.44
EBITDA 3.68
Effective Tax Rate (%) 30.86
Particulars MAR 2022 (Values in Cr)
Revenue 23.74
Operating Expense 22.63
Net Profit 0.78
Net Profit Margin (%) 3.28
Earnings Per Share (EPS) 15.63
EBITDA 3.48
Effective Tax Rate (%) 29.72
Particulars MAR 2025 (Values in Cr)
Book Value / Share 27.34
ROE % 55.32
ROCE % 34.13
Total Debt to Total Equity 1.48
EBITDA Margin 20.46
Particulars MAR 2024 (Values in Cr)
Book Value / Share 117.46
ROE % 152.90
ROCE % 40.46
Total Debt to Total Equity 5.38
EBITDA Margin 24.47
Particulars MAR 2023 (Values in Cr)
Book Value / Share 6.45
ROE % 246.00
ROCE % 16.48
Total Debt to Total Equity 0.00
EBITDA Margin 10.16
Particulars MAR 2022 (Values in Cr)
Book Value / Share -18.07
ROE % 98.00
ROCE % 15.66
Total Debt to Total Equity 0.00
EBITDA Margin 15.16
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.30
Total Assets 42.53
Total Liabilities 42.53
Total Equity 16.22
Share Outstanding 5934434
Price to Book Ratio 0.00
Return on Assets (%) 14.35
Return on Capital (%) 19.17
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.41
Total Assets 33.81
Total Liabilities 33.81
Total Equity 5.67
Share Outstanding 500000
Price to Book Ratio 0.00
Return on Assets (%) 15.84
Return on Capital (%) 23.53
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.15
Total Assets 29.66
Total Liabilities 29.66
Total Equity 0.32
Share Outstanding 500000
Price to Book Ratio 0.00
Return on Assets (%) 4.13
Return on Capital (%) 7.42
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.11
Total Assets 27.39
Total Liabilities 27.39
Total Equity -0.90
Share Outstanding 500000
Price to Book Ratio 0.00
Return on Assets (%) 1.79
Return on Capital (%) 2.94
Particulars MAR 2024 (Values in Cr)
Net Income 7.22
Cash from Operations 1.73
Cash from Investing -0.06
Cash from Financing 0.04
Net change in Cash 0.26
Free Cash Flow 1.81
Particulars MAR 2023 (Values in Cr)
Net Income 1.54
Cash from Operations 3.34
Cash from Investing -0.54
Cash from Financing -2.75
Net change in Cash 0.04
Free Cash Flow 3.96
Particulars MAR 2022 (Values in Cr)
Net Income 1.22
Cash from Operations 4.94
Cash from Investing -0.37
Cash from Financing -4.57
Net change in Cash 0.00
Free Cash Flow 5.34
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 30.76 15.08 1.59 235.72 30.00 / 68.00
BLISS GVS PHARMA LTD 161.90 15.61 1.62 1711.65 105.05 / 190.65
CIPLA LTD 1531.65 22.74 3.75 123722.28 1310.05 / 1672.20
FERMENTA BIOTECH LIMITED 291.85 7.67 2.19 858.94 219.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 30.76 25.01 4.28 235.72 30.00 / 68.00
AMRUTAJAN HEALTH LTD 719.05 36.67 6.07 2078.82 548.05 / 829.00
ASTRAZENECA PHARMA IND LT 9155.10 99.01 28.64 22887.75 6222.35 / 10653.05
BLISS GVS PHARMA LTD 161.90 21.85 1.61 1711.65 105.05 / 190.65

Curis Lifesciences Ltd shareholding pattern

Holding

Others
18.1%
Promoter Holdings
68.03%
FII
2.93%
DII
10.93%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Pawasia Siddhant J 1540000.0 (19.05%) Shareholding of Promoter and Promoter Group
Piyush Gordhanbhai Antala 1265000.0 (15.65%) Shareholding of Promoter and Promoter Group
Dharmesh D Patel 1072500.0 (13.27%) Shareholding of Promoter and Promoter Group
Patel Jaimik Mansukhlal 880000.0 (10.89%) Shareholding of Promoter and Promoter Group
Pavasiya Jayntibhai Dayaljibhai 550000.0 (6.8%) Shareholding of Promoter and Promoter Group
Mansukhbhai Patel 165000.0 (2.04%) Shareholding of Promoter and Promoter Group
Strategic Sixth Sense Capital Fund 165066.0 (2.04%) Public Shareholding
Sanshi Fund-i 157000.0 (1.94%) Public Shareholding
Maiq Growth Scheme-long Only 122000.0 (1.51%) Public Shareholding
Rs Wealth Management Private Limited 108000.0 (1.34%) Public Shareholding
Viney Growth Fund 91000.0 (1.13%) Public Shareholding
Zeta Global Funds (oeic) Pcc Limited- Zeta Series A Fund Pc 85000.0 (1.05%) Public Shareholding
Tushar Salia 27500.0 (0.34%) Shareholding of Promoter and Promoter Group

Transparent Pricing and 360° Services

Choose a Plan That Suits Your Goals and Needs

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : ₹2,500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% on Delivery 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Stock Picks by Research Analysts tick Experienced Dealer Support

News

Left Arrow
Right Arrow

Curis Lifesciences Ltd Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
141.00 0.00 redarrow
red-green-graph indicator
8 Bearish
8 Bullish
  • 5 Days 141.00
  • 26 Days 141.00
  • 10 Days 141.00
  • 50 Days 141.00
  • 12 Days 141.00
  • 100 Days 141.00
  • 20 Days 141.00
  • 200 Days 141.00
142.57 PIVOT

First Support

137.23

First Resistance

146.33

Second Support

133.47

Second Resistance

151.67

Third Support

128.13

Third Resistance

155.43

RSI

0.00

ADX

0.00

MACD

0.00

Williams % R

-75.82

Commodity Channel Index (CCI)

0.00

Date

2025-11-14

Week

1115000.00

Same Day

1115000.00

Month

1115000.00

1 Year

0.0

3 Year

0.0

Over 1 Month

0.00%

down

Over 1 Year

0.00%

down

Over 3 Months

0.00%

down

Over 3 Years

0.00%

down

Over 6 Months

0.00%

down

Over 5 Years

0.00%

down

Curis Lifesciences Ltd Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

Curis Lifesciences Ltd Share Price

Curis Lifesciences Limited was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 in the name and style of 'M/s Loreto Pharmaceutacals', pursuant to a Deed of Partnership dated 2 June, 2010. Thereafter ' M/s Loreto Pharmaceutacals' was converted from Partnership Firm to a Private Limited Company as 'Curis Lifesciences Private Limited' and received a Certificate of Incorporation dated on March 23rd, 2016 issued by Registrar of Companies, Ahmedabad. Subsequently, Company was converted into a Public Limited Company and the name of the Company was changed from 'Curis Lifesciences Private Limited' to 'Curis Lifesciences Limited' vide certified incorporated upon the conversion dated August 9, 2024, issued by the Central Processing Centre, Manesar.

Company's business is related to manufacturing of pharmaceutical products for different markets globally as well as domestic. The business is majorly on product to product basis with different marketers. Company has commenced manufacturing facility in year 2017, hence, it has experience of more than 7 years in the current line of business of the Company. The manufacturing facility of the Company is installed with capacity to manufacture 138 Crore tables / year, 15.75 Crore Capsules / year, 1,080 Kilolitre Oral Liquid/ year, 270 Tons external preparation / year and 45 Tons sterile ophthalmic ointment / year. It deal in Pharmaceutical products like Tablets, Capsules, External Preparations, Oral Liquid, Sterile Ophthalmic Ointments etc.

The Company's past and present clientele includes renowned pharma marketers and manufactures namely Arova Pharma, Express Pharmaceuticals Private Limited, Angle Biogenics Private Limited, Centurion Healthcare Private Limited, Costcon Healthcare LLP, J.B. Chemical & Pharmaceuticals Limited, Venus international, Makers Laboratories Limited and Torikaa Pharmaceuticals Limited etc. pharmaceutical manufacturing facility are situated at Sanand GIDC-II in Ahmedabad district of Gujarat, which offers easy and convenient accessibility.

Company is planning an Initial Public Issue of upto 22,50,000 Equity Shares of face value of Rs 10 each through fresh issue.

Parent organization Indian Private
NSE symbol CURIS
Founded 2016
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Curis Lifesciences Ltd?

Answer Field

Curis Lifesciences Ltd share price is for NSE ₹ 133.95 & for BSE ₹ 0.00 as on Nov 17 2025 10:01 AM.

What is the Market Cap of Curis Lifesciences Ltd Share?

Answer Field

The market cap of Curis Lifesciences Ltd for NSE ₹ 114.00 & for BSE ₹ 0.00 as on Nov 17 2025 10:01 AM.

What is the 52 Week High and Low of Curis Lifesciences Ltd?

Answer Field

The 52 Week High and Low of Curis Lifesciences Ltd for NSE is ₹ 147.90 and ₹ 138.80 and for BSE is ₹ 0.00 and ₹ 0.00.

What is 1 year return for Curis Lifesciences Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the P/E Ratio of Curis Lifesciences Ltd Share?

Answer Field

As on Nov 17 2025 10:01 AM the price-to-earnings (PE) ratio for Curis Lifesciences Ltd share is 18.68.

What is the PB ratio of Curis Lifesciences Ltd Share?

Answer Field

As on Nov 17 2025 10:01 AM, the price-to-book (PB) ratio for Curis Lifesciences Ltd share is 54.11.

How to Buy Curis Lifesciences Ltd Share?

Answer Field

You can trade in Curis Lifesciences Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Curis Lifesciences Ltd Share on Bajaj Broking App?

Answer Field

To buy Curis Lifesciences Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Curis Lifesciences Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59